| |
COVID-19: Special Considerations for People Living with HIV Updated (IDSA, HIVMA): April 4, 2020
|
| |
| |
Download the PDF here
A quick follow up on this to share the online link to this document: COVID-19: Special Considerations for People Living with HIV
This document on special considerations for people living with HIV in light of COVID-19 is intended as a resource for clinicians and public health officials. The information is based on best practices in areas that have been heavily impacted by COVID-19, and it will be updated as more information and data become available.
This link will be updated with the latest version as future updates are made.
PLW Hon treatment have a normal life expectancy. Therefore, HIV status should not be a factor in medical decision-making regarding the triaging of potentially lifesaving interventions or enrollment into clinical trials. Since HIV is eminently treatable, whether HIV is currently controlled or not should also not be factorin triaging clinical care interventions for COVID-19.
|
|
| |
| |
|
|
|
